Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Transplantation

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 97 articles:
HTML format
Text format



Single Articles


    June 2018
  1. AGARWAL K, Castells L, Mullhaupt B, Rosenberg WMC, et al
    Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients.
    J Hepatol. 2018 Jun 7. pii: S0168-8278(18)32124.
    PubMed     Text format     Abstract available


  2. THULUVATH PJ, Thuluvath AJ, Savva Y
    Karnofsky Performance Status Before and After Liver Transplantation Predicts Graft and Patient Survival.
    J Hepatol. 2018 Jun 5. pii: S0168-8278(18)32110.
    PubMed     Text format     Abstract available


    April 2018
  3. LONDONO MC, Souza LN, Lozano JJ, Miquel R, et al
    Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
    J Hepatol. 2018 Apr 27. pii: S0168-8278(18)32022.
    PubMed     Text format     Abstract available


  4. SCHLEGEL A, Kalisvaart M, Isaac J, Muiesan P, et al
    Reply to: DCD consensus and futility in Liver Transplantation.
    J Hepatol. 2018 Apr 13. pii: S0168-8278(18)31977.
    PubMed     Text format    


  5. GIORGAKIS E, Khorsandi SE, Jassem W, Heaton N, et al
    "DCD consensus and futility in Liver Transplantation".
    J Hepatol. 2018 Apr 12. pii: S0168-8278(18)31976.
    PubMed     Text format    


    March 2018
  6. MATHUR AK, Talwalkar J
    Quality measurement and improvement in liver transplantation.
    J Hepatol. 2018 Mar 17. pii: S0168-8278(18)30173.
    PubMed     Text format     Abstract available


  7. SCHLEGEL A, Kalisvaart M, Isaac J, Dutkowski P, et al
    Reply to: Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30153.
    PubMed     Text format    


  8. ONISCU GC, Watson CJE, Wigmore SJ
    Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30152.
    PubMed     Text format    


  9. LUTHER J, Dienstag JL
    Reply: Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30141.
    PubMed     Text format    


  10. DELTENRE P, Marot A, Dubois M, Trepo E, et al
    Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30142.
    PubMed     Text format    


    February 2018
  11. CRESPO G, Trota N, Londono MC, Mauro E, et al
    The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in wait-list composition.
    J Hepatol. 2018 Feb 23. pii: S0168-8278(18)30129.
    PubMed     Text format     Abstract available


  12. ASRANI SK, Saracino G, O'Leary JG, Gonzales S, et al
    Recipient characteristics and morbidity and mortality after liver transplantation.
    J Hepatol. 2018 Feb 14. pii: S0168-8278(18)30120.
    PubMed     Text format     Abstract available


  13. YOON YI, Song GW, Lee SG, Hwang S, et al
    Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    J Hepatol. 2018 Feb 13. pii: S0168-8278(18)30113.
    PubMed     Text format     Abstract available


  14. KIM AY, Sinn DH, Jeong WK, Kim YK, et al
    Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
    J Hepatol. 2018 Feb 2. pii: S0168-8278(18)30071.
    PubMed     Text format     Abstract available


    December 2017
  15. VAN VUGT JLA, Alferink LJM, Buettner S, Gaspersz MP, et al
    A Model including Sarcopenia Surpasses the MELD Score in Predicting Waiting List Mortality in Cirrhotic Liver Transplant Candidates.
    J Hepatol. 2017 Dec 5. pii: S0168-8278(17)32474.
    PubMed     Text format     Abstract available


  16. O'GRADY JG
    Relaxing Access to Liver Transplantation with Living Donation: A Foolish Move or a Time to Change?
    J Hepatol. 2017 Dec 2. pii: S0168-8278(17)32477.
    PubMed     Text format    


    November 2017
  17. FAITOT F, Besch C, Battini S, Ruhland E, et al
    Impact of real-time metabolomics in liver transplantation: graft evaluation and donor-recipient matching.
    J Hepatol. 2017 Nov 27. pii: S0168-8278(17)32447.
    PubMed     Text format     Abstract available


  18. KUBILIUN M, Patel SJ, Hur C, Dienstag JL, et al
    Early liver transplantation for alcoholic hepatitis: Ready for primetime?
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32452.
    PubMed     Text format    


  19. SCHLEGEL A, Kalisvaart M, Scalera I, Laing RW, et al
    The UK-DCD-Risk-Score: a new proposal to define futility in Donation after Circulatory Death liver transplantation.
    J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32432.
    PubMed     Text format     Abstract available


  20. LINECKER M, Krones T, Berg T, Niemann CU, et al
    Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32430.
    PubMed     Text format     Abstract available


    October 2017
  21. CHOUDHARY NS, Saraf N, Soin AS
    Liver Transplantation for Grade 3 Acute on Chronic Liver Failure: Type of Organ Failure is Important.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32401.
    PubMed     Text format    


  22. ARTRU F, Louvet A
    Reply to <<Liver transplantation for grade 3 acute-on-chronic liver failure: type of organ failure is important>>.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32402.
    PubMed     Text format    


  23. LIEBER SR, Schiano TD, Rhodes R
    Should Living Donor Liver Transplantation Be an Option When Deceased Donation Is Not?
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32405.
    PubMed     Text format     Abstract available


  24. LONDONO MC, Forns X, Pascasio JM
    Reply to: "Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations".
    J Hepatol. 2017 Oct 25. pii: S0168-8278(17)32385.
    PubMed     Text format    


  25. AZAB M, Shah S, Liu X, Ukken J, et al
    Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.
    J Hepatol. 2017 Oct 24. pii: S0168-8278(17)32390.
    PubMed     Text format    


  26. GUSTOT T, Agarwal B
    Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation.
    J Hepatol. 2017;67:667-668.
    PubMed     Text format    


    September 2017
  27. VERHOEVEN CJ, Selten JW, Roest HP, Farid WRR, et al
    Corrigendum to "MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation" [J Hepatol 2013; 59:1231-1238].
    J Hepatol. 2017 Sep 27. pii: S0168-8278(17)32279.
    PubMed     Text format    


  28. LIU X, Shen JJ, Jung Kim S, Lee YJ, et al
    Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32290.
    PubMed     Text format    


    August 2017
  29. SAMUEL D, Sanchez-Fueyo A
    Immunotherapy in liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32049.
    PubMed     Text format    


  30. PASCASIO JM, Vinaixa C, Ferrer MT, Colmenero J, et al
    Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32215.
    PubMed     Text format     Abstract available


  31. RAJAKANNU M, Coilly A, Adam R, Samuel D, et al
    Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation.
    J Hepatol. 2017 Aug 21. pii: S0168-8278(17)32214.
    PubMed     Text format    


    July 2017
  32. TRIVEDI PJ, Scalera I, Slaney E, Laing RW, et al
    Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    J Hepatol. 2017 Jul 6. pii: S0168-8278(17)32135.
    PubMed     Text format     Abstract available


    June 2017
  33. ARTRU F, Louvet A, Ruiz I, Levesque E, et al
    Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3.
    J Hepatol. 2017 Jun 20. pii: S0168-8278(17)32079.
    PubMed     Text format     Abstract available


    May 2017
  34. NADIM MK, DiNorcia J, Ji L, Groshen S, et al
    Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32003.
    PubMed     Text format     Abstract available


  35. WENDON, J, Cordoba J, Dhawan A, Larsen FS, et al
    EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.
    J Hepatol. 2017;66:1047-1081.
    PubMed     Text format     Abstract available


    April 2017
  36. COLMENERO J, Sancho-Bru P
    Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: one step at a time.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30215.
    PubMed     Text format    


  37. HIRSCHFIELD GM, Beuers U, Corpechot C, Invernizzi P, et al
    EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
    J Hepatol. 2017 Apr 17. pii: S0168-8278(17)30186.
    PubMed     Text format     Abstract available


  38. SCHWARZINGER M, Baillot S, Yazdanpanah PY, Rehm PJ, et al
    Contribution of Alcohol Use Disorders on the Burden of Chronic Hepatitis C in France, 2008-2013: A Nationwide Retrospective Cohort Study.
    J Hepatol. 2017 Apr 7. pii: S0168-8278(17)30202.
    PubMed     Text format     Abstract available


    March 2017
  39. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


  40. DETRY O, Vandermeulen M, Delbouille MH, Somja J, et al
    Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30131.
    PubMed     Text format     Abstract available


  41. BESTE LA, Green PK, Berry K, Kogut MJ, et al
    Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
    J Hepatol. 2017 Mar 3. pii: S0168-8278(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  42. SAPISOCHIN G, Barry A, Doherty M, Fischer S, et al
    Stereotactic body radiotherapy versus TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    J Hepatol. 2017 Feb 28. pii: S0168-8278(17)30119.
    PubMed     Text format     Abstract available


    November 2016
  43. NOTARPAOLO A, Layese R, Magistri P, Gambato M, et al
    Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    J Hepatol. 2016 Nov 26. pii: S0168-8278(16)30688.
    PubMed     Text format     Abstract available


  44. MALLET V, Hamed K, Schwarzinger M
    Prognosis of Patients with Chronic Hepatitis B in France (2008-2013): A Nationwide, Observational and Hospital-based Study.
    J Hepatol. 2016 Nov 5. pii: S0168-8278(16)30642.
    PubMed     Text format     Abstract available


    October 2016
  45. BHAT M, Ghali P, Dupont B, Hilzenrat R, et al
    Proposal of a Novel MELD Exception Point System for Hepatocellular Carcinoma based on Tumor Characteristics and Dynamics.
    J Hepatol. 2016 Oct 14. pii: S0168-8278(16)30571.
    PubMed     Text format     Abstract available


  46. VAN DER MEER AJ, Berenguer M
    Reversion of disease manifestations after HCV eradication.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


  47. MORADPOUR D, Grakoui A, Manns MP
    Future landscape of hepatitis C research - Basic, translational and clinical perspectives.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


    September 2016
  48. SHIN WJ, Song JG, Jun IG, Moon YJ, et al
    Effect of ventriculo-arterial coupling on transplant outcomes in cirrhotics: Analysis of pressure-volume curve relations.
    J Hepatol. 2016 Sep 26. pii: S0168-8278(16)30536.
    PubMed     Text format     Abstract available


    July 2016
  49. PAIS R, Sidney Barritt A 4th, Calmus Y, Scatton O, et al
    Nafld and liver transplantation: current burden and expected challenges.
    J Hepatol. 2016 Jul 30. pii: S0168-8278(16)30403.
    PubMed     Text format     Abstract available


  50. RUF AE, Dirchwolf M, Biggins SW, Villamil FG, et al
    Revising metrics for aggressiveness assessment in liver transplantation centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30350.
    PubMed     Text format    


  51. GOLDBERG DS, Abt PL
    Response to Revising Metrics for Aggressiveness Assessment in Liver Transplantation Centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30398.
    PubMed     Text format    


  52. YANG JD, Aqel BA, Pungpapong S, Gores GJ, et al
    Direct Acting Antiviral Therapy and Tumor Recurrence after Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.
    J Hepatol. 2016 Jul 5. pii: S0168-8278(16)30318.
    PubMed     Text format    


    June 2016
  53. COILLY A, Fougerou-Leurent C, de Ledinghen V, Houssel-Debry P, et al
    Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.
    J Hepatol. 2016 Jun 1. pii: S0168-8278(16)30253.
    PubMed     Text format     Abstract available


    May 2016
  54. BELLI LS, Berenguer M, Cortesi PA, Strazzabosco M, et al
    DELISTING OF LIVER TRANSPLANT CANDIDATES WITH CHRNIC HEPATITIC C AFTER VIRAL ERADICATION: A EUROPEAN STUDY.
    J Hepatol. 2016 May 17. pii: S0168-8278(16)30196.
    PubMed     Text format     Abstract available


  55. SCHLEGEL A, Kron P, de Oliveira ML, Clavien PA, et al
    Reply to 'Is single portal vein perfusion the best approach for machine preservation of liver grafts?'.
    J Hepatol. 2016;64:1195-6.
    PubMed     Text format    


  56. BRUGGENWIRTH IM, Burlage LC, Porte RJ, Martins PN, et al
    Is single portal vein perfusion the best approach for machine preservation of liver grafts?
    J Hepatol. 2016;64:1194-5.
    PubMed     Text format    


    April 2016
  57. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    January 2016
  58. EMOND JC, Zimmer TS
    Measuring access to liver transplantation: an overdue metric for center quality and performance.
    J Hepatol. 2016 Jan 28. pii: S0168-8278(16)00059.
    PubMed     Text format    


  59. SCHLEGEL A, Kron P, De Oliveira ML, Clavien PA, et al
    Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
    J Hepatol. 2016;64:239-41.
    PubMed     Text format    


    November 2015
  60. HONG G, Suh KS, Suh S, Yoo T, et al
    Preoperative Alpha-fetoprotein and F-FDG PET Predict Tumor Recurrence better than Milan Criteria in Living Donor Liver Transplantation.
    J Hepatol. 2015 Nov 30. pii: S0168-8278(15)00791.
    PubMed     Text format     Abstract available


  61. GOLDBERG DS, French B, Lewis JD, Scott FI, et al
    Liver transplant center variability in accepting organ offers and its impact on patient survival.
    J Hepatol. 2015 Nov 25. pii: S0168-8278(15)00773.
    PubMed     Text format     Abstract available



  62. EASL Clinical Practice Guidelines: Liver transplantation.
    J Hepatol. 2015 Nov 17. pii: S0168-8278(15)00677.
    PubMed     Text format    


    September 2015
  63. COILLY A, Samuel D
    Pros and Cons: Usage of organs from donors infected with hepatitis C virus - revision in the direct acting antiviral era.
    J Hepatol. 2015 Sep 12. pii: S0168-8278(15)00617.
    PubMed     Text format     Abstract available


    August 2015
  64. GRANCINI V, Trombetta M, Lunati ME, Zimbalatti D, et al
    Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00553.
    PubMed     Text format     Abstract available


  65. BOSCH A, Dumortier J, Maucort-Boulch D, Scoazec JY, et al
    Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
    J Hepatol. 2015 Aug 14. pii: S0168-8278(15)00545.
    PubMed     Text format     Abstract available


    July 2015
  66. MILTIADOUS O, Sia D, Hoshida Y, Fiel MI, et al
    Progenitor cell markers predict outcome of patients with Hepatocellular Carcinoma beyond Milan criteria undergoing liver transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00516.
    PubMed     Text format     Abstract available


  67. TODD STRAVITZ R, Reuben A, Mizrahi M, Lalazar G, et al
    Use of the Methacetin Breath Test to Classify the Risk of Cirrhotic Complications and Mortality in Patients Evaluated/Listed for Liver Transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00512.
    PubMed     Text format     Abstract available


  68. RAVIKUMAR R, Tsochatzis E, Jose S, Allison M, et al
    Risk Factors for Recurrent Primary Sclerosing Cholangitis After Liver Transplantation.
    J Hepatol. 2015 Jul 14. pii: S0168-8278(15)00467.
    PubMed     Text format     Abstract available


  69. YEOMAN AD, Kotha S, Heneghan MA
    Reply to "The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable".
    J Hepatol. 2015 Jul 8. pii: S0168-8278(15)00457.
    PubMed     Text format    


    June 2015
  70. DE MARTIN E, Coilly A, Ichai P, Samuel D, et al
    The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.
    J Hepatol. 2015 Jun 30. pii: S0168-8278(15)00417.
    PubMed     Text format    


  71. KOKUDO T, Hasegawa K, Uldry E, Matsuyama Y, et al
    A new formula for calculating standard liver volume for living donor liver transplantation without using body weight.
    J Hepatol. 2015 Jun 6. pii: S0168-8278(15)00384.
    PubMed     Text format     Abstract available


    April 2015
  72. MATHURIN P, Bataller R
    Trends in the management and burden of alcoholic liver disease.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  73. ADAMS DH, Sanchez-Fueyo A, Samuel D
    From immunosuppression to tolerance.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  74. BRUIX J, Han KH, Gores G, Llovet JM, et al
    Liver cancer: Approaching a personalized care.
    J Hepatol. 2015;62.
    PubMed     Text format    


  75. BERNAL W, Lee WM, Wendon J, Larsen FS, et al
    Acute liver failure: A curable disease by 2024?
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  76. MANNS MP, Lohse AW, Vergani D
    Autoimmune hepatitis - Update 2015.
    J Hepatol. 2015;62.
    PubMed     Text format    


    March 2015
  77. KARIMIAN N, Weeder PD, Bomfati F, Gouw AS, et al
    Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts.
    J Hepatol. 2015 Mar 18. pii: S0168-8278(15)00193.
    PubMed     Text format    


  78. SCHLEGEL A, Dutkowski P, Clavien PA
    Reply to: "The rescue of DCD rodent livers grafts: is there HOPE?".
    J Hepatol. 2015;62:739-41.
    PubMed     Text format    


  79. KOPP WH, Wijermars LG, Ringers J, Braat AE, et al
    The rescue of DCD rodent livers grafts: is there HOPE?
    J Hepatol. 2015;62:739.
    PubMed     Text format    


    January 2015
  80. LI H, Xia Q, Zeng B, Li ST, et al
    Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation.
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00060.
    PubMed     Text format     Abstract available


  81. ALLARD MA, Sebagh M, Ruiz A, Guettier C, et al
    Does Pathological Response for Hepatocellular Carcinoma in Patients with Cirrhosis Predict Outcome after Liver Resection or Transplantation?
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00054.
    PubMed     Text format     Abstract available


    December 2014
  82. MUSSO G, Tabibian JH, Charlton M
    Chronic kidney disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00931.
    PubMed     Text format    


  83. ALLEN AM, Ray Kim W, Heimbach JK, Rule AD, et al
    Reply to: Chronic Kidney Disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00940.
    PubMed     Text format    


  84. KLUGER MD, Salceda JA, Laurent A, Tayar C, et al
    Liver Resection For Hepatocellular Carcinoma in 313 Western Patients: Tumor Biology and Underlying Liver Rather than Tumor Size Drive Prognosis.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00939.
    PubMed     Text format     Abstract available


    November 2014
  85. LIN LT, Chung CY, Hsu WC, Chang SP, et al
    Saikosaponin b2 is a Naturally Occurring Terpenoid That Efficiently Inhibits Hepatitis C Virus Entry.
    J Hepatol. 2014 Nov 4. pii: S0168-8278(14)00807.
    PubMed     Text format     Abstract available


  86. GAMBATO M, Lens S, Navasa M, Forns X, et al
    Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    J Hepatol. 2014;61.
    PubMed     Text format     Abstract available


    August 2014
  87. JOSHITA S, Umemura T, Ota M, Tanaka E, et al
    AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00609.
    PubMed     Text format    


  88. TRIVEDI PJ, Bruns T, Li KK, Hirschfield GM, et al
    Reply to: "AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis"
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00606.
    PubMed     Text format    


  89. MOBUS S, Yang D, Yuan Q, Ludtke TH, et al
    MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.
    J Hepatol. 2014 Aug 15. pii: S0168-8278(14)00556.
    PubMed     Text format     Abstract available


  90. SANGFELT P, Sundin A, Wanders A, Rasmussen I, et al
    Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET.
    J Hepatol. 2014 Aug 8. pii: S0168-8278(14)00536.
    PubMed     Text format     Abstract available


    July 2014
  91. WEILER-NORMANN C, Lohse AW
    Acute Autoimmune Hepatitis: many open questions.
    J Hepatol. 2014 Jul 3. pii: S0168-8278(14)00460.
    PubMed     Text format    


    May 2014
  92. YEOMAN AD, Westbrook RH, Zen Y, Bernal W, et al
    Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome.
    J Hepatol. 2014 May 16. pii: S0168-8278(14)00362.
    PubMed     Text format     Abstract available


    April 2014
  93. DUTKOWSKI P, Schlegel A, de Oliveira M, Mullhaupt B, et al
    HOPE for human liver grafts obtained from donors after cardiac death.
    J Hepatol. 2014;60:765-72.
    PubMed     Text format     Abstract available


    March 2014
  94. KULIK L, Vouche M, Koppe S, Lewandowski RJ, et al
    Prospective Randomized Pilot Study of Y90 +/- Sorafenib as Bridge to Transplantation in Hepatocellular Carcinoma.
    J Hepatol. 2014 Mar 26. pii: S0168-8278(14)00204.
    PubMed     Text format     Abstract available


    January 2014
  95. PERARNAU JM, Gouge AL, Nicolas C, d'Alteroche L, et al
    Covered versus uncovered stents for Transjugular Intrahepatic Portosystemic Shunt: a randomized controlled trial.
    J Hepatol. 2014 Jan 27. pii: S0168-8278(14)00061.
    PubMed     Text format     Abstract available


    December 2013
  96. IRANMANESH P, Vazquez O, Terraz S, Majno P, et al
    Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.
    J Hepatol. 2013 Dec 19. pii: S0168-8278(13)00883.
    PubMed     Text format     Abstract available


  97. MATTER MS, Decaens T, Andersen JB, Thorgeirsson SS, et al
    Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends.
    J Hepatol. 2013 Dec 2. pii: S0168-8278(13)00833.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: